Live feed16:29:45·1494dINSIDERFilingvia QuantisnowSEC Form 4: Valliant John sold $77,694 worth of shares (10,300 units at $7.54) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 367,260 unitsByQuantisnow·Wall Street's wire, on your screen.FUSN· Fusion Pharmaceuticals Inc.Health CareOriginal source
